Beam Therapeutics Inc. SEC filings BEAM
Beam Therapeutics Inc. has 514 filings in SEC EDGAR's recent list, going back to Aug 9, 2018. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Oct 12, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| EFFECT | Filing | Sep 30, 2020 | — |
| CORRESP | Letter to the SEC | Sep 28, 2020 | — |
| CORRESP | Letter to the SEC | Sep 28, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| DRS | Filing | Sep 18, 2020 | — |
| DRSLTR | Filing | Sep 18, 2020 | — |
| EFFECT | Filing | Feb 5, 2020 | — |
| CERT | Filing | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 3, 2020 | — |
| 8-A12B | Filing | Jan 31, 2020 | — |
| CORRESP | Letter to the SEC | Jan 30, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2020 | — |
| CORRESP | Letter to the SEC | Jan 17, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 4, 2019 | — |
| CORRESP | Letter to the SEC | Oct 2, 2019 | — |
| CORRESP | Letter to the SEC | Sep 27, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2019 | — |
| DRS/A | Filing | Sep 9, 2019 | — |
| DRSLTR | Filing | Sep 6, 2019 | — |
| SEC STAFF LETTER | Filing | Aug 26, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2019 | — |
| DRS | Filing | Jul 29, 2019 | — |
| DRSLTR | Filing | Jul 26, 2019 | — |
| D | Filing | Mar 26, 2019 | — |
| D/A | Filing | Mar 26, 2019 | — |
| D | Filing | Aug 9, 2018 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BEAM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1745999
- Former names
- Beam Therapeutics Inc. (until Nov 3, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.